Canature Health Technology Co., Ltd. (SHE:300272)
China · Delayed Price · Currency is CNY 7.59
+0.01 (0.13%)
Feb 11, 2026, 3:04 PM CST
SHE:300272 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 94.76 | 83.58 | 132.45 | 92.56 | 104.86 | 26.42 |
Depreciation & Amortization | 72.67 | 72.67 | 76.91 | 75.76 | 52.12 | 37.31 |
Other Amortization | 7.06 | 7.06 | 2.31 | 4.57 | 11.6 | 9.22 |
Loss (Gain) From Sale of Assets | 0.11 | 0.11 | -2.42 | -1.55 | 0.18 | -0.83 |
Asset Writedown & Restructuring Costs | 0.05 | 0.05 | 0.09 | 15.47 | 6.52 | 21.46 |
Loss (Gain) From Sale of Investments | 30.46 | 30.46 | -5.13 | -3.74 | -35.38 | 55.02 |
Provision & Write-off of Bad Debts | 1.3 | 1.3 | 2.36 | 0.55 | 2.78 | 0.59 |
Other Operating Activities | 26.49 | 54.05 | 45.58 | 18.2 | 30.84 | 38.09 |
Change in Accounts Receivable | -9.47 | -9.47 | -4.74 | 26.17 | -137.99 | -9.26 |
Change in Inventory | -12.33 | -12.33 | 62.38 | -37.84 | -65 | -19.07 |
Change in Accounts Payable | 50.79 | 50.79 | 62.6 | -39.9 | 218.53 | -20.81 |
Change in Other Net Operating Assets | 18.63 | 18.63 | 1.64 | 0.3 | 0.47 | -3.51 |
Operating Cash Flow | 273.27 | 289.64 | 374.83 | 155.44 | 186.77 | 140.43 |
Operating Cash Flow Growth | -8.96% | -22.73% | 141.15% | -16.78% | 33.00% | 22.76% |
Capital Expenditures | -142.78 | -99.66 | -80.24 | -94.58 | -71.29 | -43.14 |
Sale of Property, Plant & Equipment | 0.23 | 0.14 | 0.57 | 2.64 | 4.7 | 5.62 |
Cash Acquisitions | - | - | - | 0 | 7.06 | - |
Divestitures | - | - | -8.43 | - | 99.88 | - |
Investment in Securities | -20.41 | -181.76 | -262.11 | 27.12 | -41.03 | 91.75 |
Other Investing Activities | 2.15 | 0.14 | - | 5.01 | 0.16 | 1.42 |
Investing Cash Flow | -160.54 | -280.88 | -349.67 | -59.81 | -0.51 | 55.65 |
Long-Term Debt Issued | - | 1,091 | 1,124 | 518.85 | 409.78 | 374.79 |
Total Debt Issued | 1,186 | 1,091 | 1,124 | 518.85 | 409.78 | 374.79 |
Long-Term Debt Repaid | - | -1,168 | -643.52 | -357.88 | -427.33 | -462.42 |
Total Debt Repaid | -1,106 | -1,168 | -643.52 | -357.88 | -427.33 | -462.42 |
Net Debt Issued (Repaid) | 80.51 | -77.05 | 480.69 | 160.97 | -17.55 | -87.63 |
Issuance of Common Stock | 2.04 | - | 44.69 | - | 2.29 | - |
Repurchase of Common Stock | -29.06 | -29.06 | - | -31.37 | -38 | -35.88 |
Common Dividends Paid | -134.96 | -181.47 | -78.16 | -69.87 | -40.86 | -42.22 |
Other Financing Activities | 11.34 | -11.67 | -16.94 | -28.75 | -2.49 | -16.43 |
Financing Cash Flow | -70.13 | -299.24 | 430.29 | 30.98 | -96.6 | -182.16 |
Foreign Exchange Rate Adjustments | 11.9 | 12.34 | 20.45 | 14.82 | 0.84 | 7.3 |
Net Cash Flow | 54.51 | -278.14 | 475.9 | 141.43 | 90.49 | 21.22 |
Free Cash Flow | 130.49 | 189.98 | 294.59 | 60.85 | 115.48 | 97.29 |
Free Cash Flow Growth | -40.35% | -35.51% | 384.12% | -47.30% | 18.70% | 75.18% |
Free Cash Flow Margin | 7.29% | 11.25% | 17.62% | 3.66% | 7.64% | 8.24% |
Free Cash Flow Per Share | 0.23 | 0.33 | 0.51 | 0.11 | 0.20 | 0.18 |
Cash Income Tax Paid | 57.77 | 61.31 | 45.22 | 18.42 | 19.91 | 25.32 |
Levered Free Cash Flow | 86.43 | 85.83 | 165.73 | 107.38 | 107.21 | 27.78 |
Unlevered Free Cash Flow | 108.4 | 107.38 | 183.5 | 117.91 | 117.39 | 37.18 |
Change in Working Capital | 40.36 | 40.36 | 122.68 | -46.38 | 13.25 | -46.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.